Skip to main content

NAS/NOWS, Neonatal — Evaluation and Scoring — Clinical Pathway: Inpatient Care

Neonatal Abstinence Syndrome (NAS) /Neonatal Opioid Withdrawal Syndrome (NOWS), Clinical Pathway, Inpatient

Evaluation and Scoring Systems: ESC and Finnegan

Finnegan Eat Sleep Console (ESC)
  • Based on a study published by Dr. Finnegan in 1975
  • Evaluates an infant in 21 different categories
  • No randomized controlled trials to support this tool over other scoring tools. No research to validate the severity or inclusion of any of the 21 categories
  • Requires frequently disturbing the infant in order to evaluate
  • Focus is on pharmacologic treatment and management
  • Gained widespread clinical use despite an AAP statement in 1998 that recommended another tool
  • No randomized controlled trials to support beginning medications with scores of 8
  • Dr. Finnegan’s original paper did not address weaning of medication
  • No long-term data for infants managed with pharmacologic treatment
  • Based on study published by Dr. Grossman in 2018
  • Evaluates infant’s ability to eat, sleep, and be consoled
  • No randomized controlled trials to support this tool but there is a current national trial to evaluate in comparison to Finnegan
  • Allows for on-demand care and minimized disruption of infant
  • Focus is on non-pharmacologic management and parental involvement
  • Original study discourages conversion into a scoring tool and stresses ongoing evaluation, which can create a challenge in clinical setting
  • Emerging publications to develop a scoring tool and interrater reliability training
  • No long-term data for infants managed without pharmacologic treatment, but ongoing data collection in process to evaluate this

 

Jump back to top